Evidence map›Paper›PMID 34761146›Full record

ReviewJBMR plus2021

Health Effects of Calcium: Evidence From Mendelian Randomization Studies.

Yiheng Chen, Vincenzo Forgetta, J Brent Richards, Sirui Zhou

Open access · goldAbstract readReview
In one paragraph

Review in JBMR plus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Calcium Supplementation- Efficacy and Safety.Current osteoporosis reports · 2025
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Yiheng ChenDepartment of Human Genetics McGill University Montréal QC Canada.ORCID https://orcid.org/0000-0002-7662-9441
Vincenzo ForgettaLady Davis Institute, Jewish General Hospital McGill University Montréal QC Canada.ORCID https://orcid.org/0000-0002-6061-4720
J Brent RichardsDepartment of Human Genetics McGill University Montréal QC Canada.ORCID https://orcid.org/0000-0002-3746-9086
Sirui ZhouLady Davis Institute, Jewish General Hospital McGill University Montréal QC Canada.ORCID https://orcid.org/0000-0003-4963-0815
Jewish General Hospital · CAKing's College London · GBMcGill University Health Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Calcium is widely used in conjunction with vitamin D to prevent osteoporosis. The use of calcium supplementation is also promoted for its potential benefits in lowering the risk for metabolic syndromes and cancers. However, the causal link between calcium and various health outcomes remains unclear. This review focuses on the evidence from 24 Mendelian randomization (MR) studies that were designed to minimize bias from confounding and reverse causation. These MR studies evaluated the effect of lifelong genetically higher serum calcium levels on various health outcomes. Overall, available MR studies found no conclusive effects of serum calcium levels on bone mineral density and fracture, ischemic stroke and heart failure, cancers, type 2 diabetes, Parkinson disease, or offspring birth weight. However, a higher serum calcium concentration was reported to have estimated causal effects on increased risks for coronary artery disease (especially myocardial infarction), migraine, renal colic, allergy/adverse effect of penicillin, and reduced risks for osteoarthrosis and osteoarthritis. In conclusion, supplementation of calcium in individuals from the general population is not predicted to influence the risk of most investigated diseases to date. Moreover, long-term high serum calcium concentrations may result in adverse health outcomes. © 2021 The Authors.

Indexed as

CALCIUMCANCERCARDIOVASCULAR DISEASEMENDELIAN RANDOMIZATIONMUSCULOSKELETAL DISEASES

Identifiers

PMID34761146
PMCPMC8567492
OpenAlexW3194908720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.